CRL Global Services Builds European Lab in UK
CRL Global Services (Kansas), an independent clinical testing laboratory operation, has concluded a deal with Quotient Bioresearch (Cambridgeshire, UK) that will see CRL Global Services establish its new European laboratory hub in the UK.
CRL Global Services has chosen to construct its own laboratory in Cambridgeshire, UK, embedded within the existing facilities of Quotient Bioresearch. It will provide a further full service laboratory arm to CRL Global Services’ existing global structure. The contract also provides for an immediate close collaboration between the companies on the development and delivery of new services, particularly in the areas of bioanalysis, biomarkers, and microbiology.
David Griffiths, PhD MBA, business development director, Quotient Bioresearch, added: “We are very pleased to be working together with CRL Global Services as they construct their new laboratory in the UK. The established capabilities of the two companies are entirely complementary. I anticipate synergies that will enable us to deliver a joint offering significantly broader than available from each party working alone.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
